Abstract

Background

T-cell responses during chronic viral infections become exhausted, which is reflected by upregulation of inhibitory receptors (iRs) and increased interleukin 10 (IL-10). We assessed 2 iRs—PD-1 (programmed cell death protein 1) and Tim-3 (T-cell immunoglobulin and mucin domain–containing protein 3)—and IL-10 mRNAs in peripheral blood mononuclear cells (PBMCs) and their soluble analogs (sPD-1, sTim-3, and IL-10) in plasma in chronic HIV-1/hepatitis C virus (HCV) coinfection and explored the effect of HCV treatment on these markers. We also aimed to establish whether iR expression may be determined by the HCV CD8+ T-cell immunodominant epitope sequence.

Methods

Plasma and PBMCs from 31 persons with chronic HIV-1/HCV coinfection from the Swiss HIV Cohort Study were collected before and after HCV treatment. As controls, 45 persons who were HIV-1 negative with chronic HCV infection were recruited. Exhaustion markers were assessed by enzyme-linked immunosorbent assay in plasma and by quantitative reverse transcription polymerase chain reaction in PBMCs. Analysis of an HCV epitope sequence was conducted by next-generation sequencing: HLA-A*02–restricted NS31073–1081 and NS31406–1415 and HLA-A*01–restricted NS31436–1444.

Results

The study revealed higher plasma sPD-1 (P = .0235) and IL-10 (P = .002) levels and higher IL-10 mRNA in PBMCs (P = .0149) in HIV-1/HCV coinfection. A decrease in plasma sPD-1 (P = .0006), sTim-3 (P = .0136), and IL-10 (P = .0003) and Tim-3 mRNA in PBMCs (P = .0210) was observed following successful HCV treatment. Infection with the HLA-A*01–restricted NS31436–1444 ATDALMTGY prototype variant was related to higher sTim-3 levels than infection with the ATDALMTGF escape variant (P = .0326).

Conclusions

The results underscore the synergistic effect of coinfection on expression of exhaustion markers, their reduction following successful HCV treatment and imply that iR levels may operate on an epitope-specific manner.

Details

Title
T-Cell Exhaustion in HIV-1/Hepatitis C Virus Coinfection Is Reduced After Successful Treatment of Chronic Hepatitis C
Author
Kamila Caraballo Cortés 1   VIAFID ORCID Logo  ; Osuch, Sylwia 1 ; Perlejewski, Karol 1 ; Radkowski, Marek 1 ; Janiak, Maciej 1 ; Berak, Hanna 2 ; Rauch, Andri 3 ; Fehr, Jan S 4 ; Hoffmann, Matthias 5 ; Günthard, Huldrych F 6 ; Metzner, Karin J 6 

 Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw , Warsaw , Poland 
 Outpatient Clinic, Warsaw Hospital for Infectious Diseases , Warsaw , Poland 
 Department of Infectious Diseases, Bern University Hospital, University of Bern , Bern , Switzerland 
 Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich , Zurich , Switzerland 
 Division of Infectious Diseases, Cantonal Hospital Olten , Olten , Switzerland 
 Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich , Switzerland 
Publication year
2023
Publication date
Nov 2023
Publisher
Oxford University Press
e-ISSN
23288957
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3170944410
Copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.